BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16407823)

  • 1. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia.
    De Toni F; Racaud-Sultan C; Chicanne G; Mas VM; Cariven C; Mesange F; Salles JP; Demur C; Allouche M; Payrastre B; Manenti S; Ysebaert L
    Oncogene; 2006 May; 25(22):3113-22. PubMed ID: 16407823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
    Xiao Y; Deng T; Ming X; Xu J
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.
    Lagadinou ED; Ziros PG; Tsopra OA; Dimas K; Kokkinou D; Thanopoulou E; Karakantza M; Pantazis P; Spyridonidis A; Zoumbos NC
    Leukemia; 2008 Oct; 22(10):1899-908. PubMed ID: 18650843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors.
    Bertrand J; Despeaux M; Joly S; Bourogaa E; Gallay N; Demur C; Bonnevialle P; Louache F; Maguer-Satta V; Vergnolle N; Payrastre B; Racaud-Sultan C
    Oncogene; 2012 Feb; 31(6):694-705. PubMed ID: 21725365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
    Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
    PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML).
    Omsland M; Bruserud Ø; Gjertsen BT; Andresen V
    Oncotarget; 2017 Jan; 8(5):7946-7963. PubMed ID: 27974700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and molecular characterization of polymeric micro-nanofibrous scaffold of a defined 3-D niche for in vitro chemosensitivity analysis against acute myeloid leukemia cells.
    Nair MS; Mony U; Menon D; Koyakutty M; Sidharthan N; Pavithran K; Nair SV; Menon KN
    Int J Nanomedicine; 2015; 10():3603-22. PubMed ID: 26028971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia.
    Qiu L; Zhou G; Cao S
    Life Sci; 2020 Feb; 243():117234. PubMed ID: 31887299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
    Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
    Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC8 promotes daunorubicin resistance of human acute myeloid leukemia cells via regulation of IL-6 and IL-8.
    Wu J; Zhang L; Feng Y; Khadka B; Fang Z; Liu J
    Biol Chem; 2021 Mar; 402(4):461-468. PubMed ID: 33938176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
    Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells.
    Suzuki A; Ozono K; Kubota T; Kondou H; Tachikawa K; Michigami T
    J Cell Biochem; 2008 May; 104(1):304-17. PubMed ID: 17990294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network.
    Carter BZ; Mak PY; Chen Y; Mak DH; Mu H; Jacamo R; Ruvolo V; Arold ST; Ladbury JE; Burks JK; Kornblau S; Andreeff M
    Oncotarget; 2016 Apr; 7(15):20054-67. PubMed ID: 26956049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
    Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
    Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hammada scoparia flavonoids and rutin kill adherent and chemoresistant leukemic cells.
    Bourogaa E; Bertrand J; Despeaux M; Jarraya R; Fabre N; Payrastre L; Demur C; Fournié JJ; Damak M; Feki AE; Racaud-Sultan C
    Leuk Res; 2011 Aug; 35(8):1093-101. PubMed ID: 21216465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased pressure alters plasma membrane dynamics and renders acute myeloid leukemia cells resistant to daunorubicin.
    Nirmalanandhan VS; Hurren R; Cameron WD; Gronda M; Shamas-Din A; You L; Minden MD; Rocheleau JV; Schimmer AD
    Haematologica; 2015 Oct; 100(10):e406-8. PubMed ID: 26185171
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells.
    Zhang H; Xu H; Zhang R; Zhao X; Liang M; Wei F
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):257-266. PubMed ID: 32696214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells.
    De Toni-Costes F; Despeaux M; Bertrand J; Bourogaa E; Ysebaert L; Payrastre B; Racaud-Sultan C
    PLoS One; 2010 Mar; 5(3):e9807. PubMed ID: 20352103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.